Search

Displaying results 7731 - 7740 of 10000 in total
  1. Drug

    Carrimycin

    go.drugbank.com/drugs/DB16476
    Investigational

  2. Drug

    Valtorcitabine

    go.drugbank.com/drugs/DB06187
    Investigational

  3. Drug

    Dersalazine

    go.drugbank.com/drugs/DB06251
    Investigational

  4. Drug

    Naxifylline

    go.drugbank.com/drugs/DB06471
    Experimental

  5. Drug

    Lerdelimumab

    go.drugbank.com/drugs/DB06557
    Experimental

  6. Drug

    Celgosivir

    go.drugbank.com/drugs/DB06580
    Investigational

  7. Drug

    Triphendiol

    go.drugbank.com/drugs/DB06588
    Experimental

  8. Drug

    RO7296682

    go.drugbank.com/drugs/DB17531
    Investigational

    RO7296682 is under investigation in clinical trial NCT04642365 (A Study to Evaluate the Safety and Tolerability of RO7296682 in Combination With Atezolizumab in Participants With Advanced Solid Tumors. … RO7296682 is a monoclonal antibody against CD25 (IL-2R alpha) expressed on tumour-infiltrating regulatory T (T<sub>reg</sub>) cells.

  9. Drug

    Luveltamab tazevibulin

    go.drugbank.com/drugs/DB17563
    Investigational

    [A257414] It is under investigation in clinical trial NCT05200364 (A Study of STRO-002, an Anti-folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer … Luveltamab tazevibulin, formerly known as STRO-002, is novel homogeneous folate receptor alpha (FolRα) targeting antibody-drug conjugate.

  10. Drug

    Mubodina

    go.drugbank.com/drugs/DB17616
    Experimental

    Mubodina is an investigational drug developed by Adienne Pharma & Biotech. It is a recombinant human minibody directed against complement component C5. … It was investigated in various conditions including primary membranoproliferative glomerulonephritis and typical hemolytic uremic syndrome.